This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

5 Defensive Stocks to Protect Your Portfolio Gains - views

CVS Caremark

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Shareholders of CVS Caremark (CVS) are having a solid 2013 -- shares of the retail pharmacy and benefits manager have rallied almost 25% so far this year. CVS has had some good timing lately. The firm acquired Caremark in 2007, buying exposure to a stable pharmacy benefit manager just as the floor was falling out of the economy; as a result, CVS actually managed to grow during the recession.

Today, CVS Caremark boasts more than 7,000 retail pharmacies and benefits management for around 1 billion prescriptions each year. More recently, the introduction of MinuteClinic health clinic locations at around 500 of CVS' retail locations has provided attractive exposure to a growing corner of the healthcare business. As healthcare costs continue to push consumers away from conventional physicians' offices, cheaper alternatives like MinuteClinic offer a big advantage for health screenings and minor medical treatment.

The addition of MinuteClinic to CVS' stable of offerings is important for another reason -- it creates a complete vertical integration of healthcare provider, benefits management and retail pharmacy, a combination that should keep costs low and incentivize customers to use CVS each step of the way. Of the defensive names on our list, CVS has the biggest differential between its bull market beta and its bear market beta. That means that this stock benefits way more when times are good than it suffers when they aren't.

I also featured CVS in "5 Trading Setups With Upside This Week."

5 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,050.71 +71.58 0.42%
S&P 500 1,990.96 +4.45 0.22%
NASDAQ 4,523.5330 -2.9490 -0.07%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs